Review



proviral dna population and next-generation sequencing genotyping  (GenPro Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenPro Inc proviral dna population and next-generation sequencing genotyping
    Demographic and Baseline characteristics for the enrolled participants (n=41).
    Proviral Dna Population And Next Generation Sequencing Genotyping, supplied by GenPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proviral+dna+population+and+next-generation+sequencing+genotyping/proviral+dna+population+and+next+generation+sequencing+genotyping/pmc07225620-123-21-28
    Average 90 stars, based on 1 article reviews
    proviral dna population and next-generation sequencing genotyping - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)"

    Article Title: Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)

    Journal: EBioMedicine

    doi: 10.1016/j.ebiom.2020.102779

    Demographic and Baseline characteristics for the enrolled participants (n=41).
    Figure Legend Snippet: Demographic and Baseline characteristics for the enrolled participants (n=41).

    Techniques Used: Biomarker Discovery, Transmission Assay, Clinical Proteomics, DNA Sequencing

    Related Articles

    Next-Generation Sequencing:

    Article Title: Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
    Article Snippet: .. Participants were selected from our prior study that evaluated the concordance in detecting persistence of resistance-associated mutations in aviremic persons using proviral DNA population and next-generation sequencing genotyping (“GEN-PRO”) . .. In GEN-PRO study visit, we obtained samples for peripheral blood proviral DNA genotyping (Sanger sequencing using Big Dye Terminator (Applied Biosystem), and the Stanford HIVDB algorithm to interpret resistance mutations) and peripheral blood mononuclear cells (PBMCs) to retrospectively perform next-generation sequencing.



    Similar Products

    proviral dna population and next-generation sequencing genotyping  (GenPro Inc)
    90
    GenPro Inc proviral dna population and next-generation sequencing genotyping
    Demographic and Baseline characteristics for the enrolled participants (n=41).
    Proviral Dna Population And Next Generation Sequencing Genotyping, supplied by GenPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proviral+dna+population+and+next-generation+sequencing+genotyping/proviral+dna+population+and+next+generation+sequencing+genotyping/pmc07225620-123-21-28
    Average 90 stars, based on 1 article reviews
    proviral dna population and next-generation sequencing genotyping - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Demographic and Baseline characteristics for the enrolled participants (n=41).

    Journal: EBioMedicine

    Article Title: Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)

    doi: 10.1016/j.ebiom.2020.102779

    Figure Lengend Snippet: Demographic and Baseline characteristics for the enrolled participants (n=41).

    Article Snippet: Participants were selected from our prior study that evaluated the concordance in detecting persistence of resistance-associated mutations in aviremic persons using proviral DNA population and next-generation sequencing genotyping (“GEN-PRO”) .

    Techniques: Biomarker Discovery, Transmission Assay, Clinical Proteomics, DNA Sequencing